This is a health supplement and not a medicine
Our experienced medical team at Contour Medical Spa works closely with each client to create a personalized plan, ensuring the best possible results with safe and supportive care
Archived from the original on August 14, 2022
Recent progress in AOMs, especially semaglutide and tirzepatide, has demonstrated encouraging outcomes in managing obstructive sleep apnea in individuals with obesity
To these is now added a new class of oral drugs, tyrosine kinase two inhibitors, such as Deucravacitinib, approved by regulatory authorities to offer potent systemic efficacy with the convenience of oral administration, representing a valid alternative for patients who prefer to avoid injections
Approval of new medications will introduce competition and may lower unit cost